Skip to content

Compare medicines

Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.

Attribute
In shortOnce-daily sulfonylurea.Sulfonylurea that boosts insulin release.
Body systemDiabetes & WeightDiabetes & Weight
Drug classSulfonylureasSulfonylureas
SupplyPrescription onlyPrescription onlyWHO essential medicine
Main usesType 2 diabetesType 2 diabetes
How it worksReleases more insulin from the pancreas.Tells your pancreas to release more insulin.
Starts working——
Half-life5–8 hours10–12 hours
Typical adult dose1–4 mg once a day with breakfast (maximum 6–8 mg).40–320 mg a day (split if over 160 mg); modified-release 30–120 mg once a day with breakfast.
FormsTablet, Combination tablets with metforminTablet, Modified-release tablet
Common side effectsLow blood sugar, Weight gain, DizzinessLow blood sugar, Weight gain, Stomach upset
Serious side effectsSevere hypoglycaemiaSevere hypoglycaemia, Liver or blood problems (rare)
Don't take ifType 1 diabetes or ketoacidosis; Severe kidney or liver impairment; Allergy to sulfonylureasType 1 diabetes or ketoacidosis; Severe kidney or liver impairment; Allergy to sulfonylureas; Taking miconazole
AlcoholBest to limit. Alcohol raises the risk of severe low blood sugar.Best to limit. Alcohol raises the risk of severe low blood sugar.
PregnancyUsually avoidedSwitch to insulin.Usually avoidedUsually switched to insulin or metformin.
BreastfeedingUsually avoidedAvoid; insulin preferred.Usually avoidedAvoid; insulin preferred.
In use since19951972
Brand namesUnited States: AmarylUnited Kingdom: AmarylIndia: Amaryl, Glimy, Glimestar, Gemer (with metformin)United Kingdom: Diamicron, ZicronIndia: Glizid, Reclide, DiamicronAustralia: Diamicron MR
Legal statusUnited States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule HUnited States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H
ATC codeA10BB12A10BB09

Taken together

  • MinorGlimepiride + Gliclazide: More risk of low blood sugar

    Both medicines lower blood sugar; combinations are common but hypos become more likely.

Open in the interaction checker